Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Parenting, Pregnancy, and Prevention (March) | 2019

View Archived Issues

CME Post-Test - Parenting, Pregnancy, and Prevention, TCPR, March 2019

March 29, 2019

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit. Read More

Ask the Editor: Should You Prescribe Lithium to Suicidal Patients?

March 29, 2019

Chris Aiken, MD.

It would seem intuitive, then, that withholding lithium, which is toxic in overdose, from a suicidal patient is a safe move. However, intuition doesn’t match up with the evidence here. Read More

Amphetamines Stand Out in ADHD

March 29, 2019

Michael Posternak, MD.

With so many medications available to treat ADHD, wouldn’t it be nice to know if some are better than others? In this comprehensive meta-analysis, researchers sought to compare the relative efficacy and tolerability of both stimulant and non-stimulant medications for ADHD in children and adults. Read More

What Can Our Pregnant Patients Do to Prevent Mental Illness in Their Children?

March 29, 2019

Robert Freedman, MD

During pregnancy, untreated depression significantly increases the risk that the infant will fail to develop adequate levels of cerebral inhibition. That’s a measure of the infant’s ability to filter out irrelevant stimuli, and it’s the first sign that development is not on an optimal track. Read More

Parenting Strategies for Patients With Mental Illness

March 29, 2019

Marie Yap, PhD

“To love and work” was how Freud saw the goal of psychiatric treatment. Mental illness robs people of many meaningful roles, from work to parenting. We spoke with Marie Yap, director of the award-winning Parenting Strategies program, to learn how to help our patients function better as parents and prevent psychiatric disorders in their children. Read More

A Second Look at Genetic Testing

March 29, 2019

Chris Aiken, MD.

Genetic tests are marketed with a bold claim: that a handful of genes can predict medication response. AssureRx’s GeneSight is the most popular of these tests, and in 2015 we reviewed the evidence behind its panel. In short, it was lacking, but the company has just released new data that may move it a little closer to the mainstream. Read More